We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
After a prolonged period of 10-year bond yields relatively stagnant in the 2.8s earlier this year — while equity markets were setting a wild roller coaster in motion — we now see the 10-year peek its head up near 3% for the first time since the end of 2013. At 2.966%, market participants are beginning to pay close attention here, with a ratcheted-up bond yield signifying things like increased economic inflation, which would likely prompt the Fed to raise interest rates higher, faster.
Also of interest, not of actual concern just yet, to the market is the tight spread between the 10-year bond yield and the 2-year, which is currently the lowest it’s been since 2007 — which is an important benchmark historically, as it came the year Bear Stearns crumbled and ahead of the economic meltdown of 2008 which led to the Great Recession. An inversion of the yield curve — when the 2-year yield pays out more than the 10-year — is a signifier to economists that another recession may be on the way.
To be clear, we’re not seeing that inversion currently. We’re not even seeing a 3% bond yield in the 10-year, which itself is still historically low. But taking into context the Goldilocks economy we’ve been enjoying the past several years — with increased traction in employment growth and a new tax windfall for corporations in 2018 — that we may be emerging into pricier territory (and, by the way, CNBC’s Steve Liesman reports this morning the odds of a fourth rate hike this year has recently blossomed to 30%) may jostle equities indexes in a manner 2018 had already begun to grow accustomed to.
Ahead of the opening bell today, oilfield services major Halliburton (HAL - Free Report) met estimates on its bottom line at 41 cents per share, while posting a revenue number a smidge below the Zacks consensus to 5.74 billion. Operating income for Halliburton was up big year over year, but still below what analysts had been expecting. For more on HAL’s earnings, click here.
Partly due to the bankruptcy of Toys R Us stores in the Q1 this year, toy-making giant Hasbro (HAS - Free Report) missed earnings and sales estimates by a wide margin: 10 cents per share versus 31 cents expected, on $716 million in revenues that was far below the Zacks consensus $825 million. Hasbro shares are down another 4.5% in today’s pre-market, and precipitously off the $115+ share price from last summer. For more on HAS’s earnings, click here.
Here’s a Q1 earnings beat this morning: Zacks Rank #3 (Hold)-rated Alaska Air Group (ALK - Free Report) , whose 14 cents per share beat consensus by 3 cents, and revenues in the quarter marginally topped expectations to $1,831 million. This top line number is also favorable from the $1,749 million in the year-ago quarter. The regional airline saw solid metrics offset somewhat by a 20% rise in jet fuel costs. For more on ALK’s earnings, click here.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Q1 Earnings, 10-Year Yield Heating Up
Monday, April 23, 2018
After a prolonged period of 10-year bond yields relatively stagnant in the 2.8s earlier this year — while equity markets were setting a wild roller coaster in motion — we now see the 10-year peek its head up near 3% for the first time since the end of 2013. At 2.966%, market participants are beginning to pay close attention here, with a ratcheted-up bond yield signifying things like increased economic inflation, which would likely prompt the Fed to raise interest rates higher, faster.
Also of interest, not of actual concern just yet, to the market is the tight spread between the 10-year bond yield and the 2-year, which is currently the lowest it’s been since 2007 — which is an important benchmark historically, as it came the year Bear Stearns crumbled and ahead of the economic meltdown of 2008 which led to the Great Recession. An inversion of the yield curve — when the 2-year yield pays out more than the 10-year — is a signifier to economists that another recession may be on the way.
To be clear, we’re not seeing that inversion currently. We’re not even seeing a 3% bond yield in the 10-year, which itself is still historically low. But taking into context the Goldilocks economy we’ve been enjoying the past several years — with increased traction in employment growth and a new tax windfall for corporations in 2018 — that we may be emerging into pricier territory (and, by the way, CNBC’s Steve Liesman reports this morning the odds of a fourth rate hike this year has recently blossomed to 30%) may jostle equities indexes in a manner 2018 had already begun to grow accustomed to.
Otherwise, the big news this week continues to be Q1 earnings season, which really hits the accelerator with Alphabet (GOOGL - Free Report) reporting after the bell today, along with Caterpillar (CAT - Free Report) , Verizon (VZ - Free Report) , Amazon (AMZN - Free Report) , Intel (INTC - Free Report) and Exxon (XOM - Free Report) , among others later this week. As Zacks Director of Research Sheraz Mian points out in his latest Earnings Preview, by the end of this week we’ll be more than halfway through the S&P 500’s quarterly earnings: Positive Revenue Surprises Lag Previous Quarter Levels
Ahead of the opening bell today, oilfield services major Halliburton (HAL - Free Report) met estimates on its bottom line at 41 cents per share, while posting a revenue number a smidge below the Zacks consensus to 5.74 billion. Operating income for Halliburton was up big year over year, but still below what analysts had been expecting. For more on HAL’s earnings, click here.
Partly due to the bankruptcy of Toys R Us stores in the Q1 this year, toy-making giant Hasbro (HAS - Free Report) missed earnings and sales estimates by a wide margin: 10 cents per share versus 31 cents expected, on $716 million in revenues that was far below the Zacks consensus $825 million. Hasbro shares are down another 4.5% in today’s pre-market, and precipitously off the $115+ share price from last summer. For more on HAS’s earnings, click here.
Here’s a Q1 earnings beat this morning: Zacks Rank #3 (Hold)-rated Alaska Air Group (ALK - Free Report) , whose 14 cents per share beat consensus by 3 cents, and revenues in the quarter marginally topped expectations to $1,831 million. This top line number is also favorable from the $1,749 million in the year-ago quarter. The regional airline saw solid metrics offset somewhat by a 20% rise in jet fuel costs. For more on ALK’s earnings, click here.
Mark Vickery
Senior Editor
Questions or comments about this article and/or its author? Click here>>
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>